High-risk molecular prognostic markers found in each genomically-defined CLL subgroup.

An evaluation of molecular prognostic markers found in the genomically-defined CLL subgroups identifies significantly different levels of these markers between the subgroups (p<0.0001, Pearson’s Chi-squared test for each prognostic marker). Results are reported as percentage of samples within a group with each high-risk prognostic marker, calculated as number with the prognostic marker divided by the total within the subgroup with data available.